Cargando…

The potential roles of m(6)A modification in regulating the inflammatory response in microglia

BACKGROUND: Microglia are key regulators of the inflammatory response in the brain. Adenosine in RNAs can be converted to m(6)A (N(6)-methyladenosine), which regulates RNA metabolism and functions as a key epitranscriptomic modification. The m(6)A modification pattern and m(6)A-related signatures un...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Qi, Wen, Shaohong, Ye, Weizhen, Zhao, Shunying, Liu, Xiangrong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8259013/
https://www.ncbi.nlm.nih.gov/pubmed/34225746
http://dx.doi.org/10.1186/s12974-021-02205-z
Descripción
Sumario:BACKGROUND: Microglia are key regulators of the inflammatory response in the brain. Adenosine in RNAs can be converted to m(6)A (N(6)-methyladenosine), which regulates RNA metabolism and functions as a key epitranscriptomic modification. The m(6)A modification pattern and m(6)A-related signatures under pro-inflammatory and anti-inflammatory conditions of microglia remain unclear. METHODS: Primary rat microglia were differentiated into pro-inflammatory M1-like (M1-L), anti-inflammatory M2-like (M2-L), and resting, unstimulated (M0-L) phenotypes. m(6)A mRNA and lncRNA epitranscriptomic microarray analyses were performed, and pathway analysis was conducted to understand the functional implications of m(6)A methylation in mRNAs and lncRNAs. The m(6)A methylation level and gene expression of mRNAs and lncRNAs were subsequently verified by m(6)A Me-RIP and qRT-PCR. RESULTS: A total of 1588 mRNAs and 340 lncRNAs, 315 mRNAs and 38 lncRNAs, and 521 mRNAs and 244 lncRNAs were differentially m(6)A methylated between M1-L and M0-L (M1-L/M0-L), M2-L and M0-L (M2-L/M0-L), M2-L and M1-L (M2-L/M1-L), respectively. Furthermore, 4902 mRNAs, 4676 mRNAs, and 5095 mRNAs were identified distinctively expressed in M1-L/M0-L, M2-L/M0-L, and M2-L/M1-L, respectively. Pathway analysis of differentially m(6)A methylated mRNAs and lncRNAs in M1-L/M0-L identified immune system, signal transduction, and protein degradation processes. In contrast, the distinct m(6)A methylated mRNAs in M2-L/M0-L were involved in genetic information processing, metabolism, cellular processes, and neurodegenerative disease-related pathways. We validated m(6)A methylation and the expression levels of five mRNAs and five lncRNAs, which were involved in upregulated pathways in M1-L/M0-L, and five mRNAs involved in upregulated pathways in M2-L/M0-L. CONCLUSIONS: These findings identify a distinct m(6)A epitranscriptome in microglia, and which may serve as novel and useful regulator during pro-inflammatory and anti-inflammatory response of microglia. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12974-021-02205-z.